1Mechanisms implicated in the contralateral effect in the central nervous system after unilateral injury: focus on the visual systemReviews2125-2131
2Toward three-dimensional in vitro models to study neurovascular unit functions in health and diseaseReviews2132-2140
3Apolipoprotein A1, the neglected relative of Apolipoprotein E and its potential role in Alzheimer's diseaseReviews2141-2148
5Non-coding RNAs and other determinants of neuroinflammation and endothelial dysfunction: regulation of gene expression in the acute phase of ischemic stroke and possible therapeutic applicationsReviews2154-2158
6Altered microRNA expression in animal models of Huntington's disease and potential therapeutic strategiesReviews2159-2169
9Neuroimmune connections between corticotropin- releasing hormone and mast cells: novel strategies for the treatment of neurodegenerative diseasesReviews2184-2197
11Mitofusin activation enhances mitochondrial motility and promotes neuroregeneration in CMT2APerspectives2201-2203
14Evaluation of glial cell proliferation with non-invasive molecular imaging methods after strokePerspectives2209-2210
15It takes more than tau to tangle: using proteomics to determine how phosphorylated tau mediates toxicity in neurodegenerative diseasesPerspectives2211-2212
16A biophysical perspective on the unexplored mechanisms driving Parkinson's disease by amphetamine-like stimulantsPerspectives2213-2214
18Diagnostic and therapeutic potential of exosomal miRNAs in Alzheimer's diseasePerspectives2217-2218
19Alpha-synuclein preformed fibrils: a tool to understand Parkinson's disease and develop disease modifying therapyPerspectives2219-2221
20Exploring the contribution of the mitochondrial disulfide relay system to Parkinson's disease: the PINK1/CHCHD4 interplayPerspectives2222-2224
